Printer Friendly

IMMUNEX NAMES NEW COMMUNICATIONS VICE PRESIDENT

 SEATTLE, June 17 /PRNewswire/ -- Immunex Corp. (NASDAQ: IMNXD) announced today the promotion of Valoree E. Dowell to the position of vice president, corporate communications, effective July 1. She will be responsible for managing the company's investor and media relations and employee communications activities. Dowell, who had been director of communications since 1988, succeeds Jason Rubin who is joining Cephalon Inc. as vice president, corporate communications.
 "Valoree has helped manage our communications efforts during a challenging time for our company and our industry," said Immunex Chairman and Chief Executive Officer Stephen A. Duzan. "She has played an important role on Immunex's management team and we are pleased to recognize her commitment and contributions to the company's success."
 Dowell is a director of the National Investor Relations Institute and a member of the Issuer Affairs Committee of NASDAQ. She joined Immunex in 1985.
 Immunex is a biopharmaceutical company focused on the discovery, development, manufacture and marketing of products to treat cancer and autoimmune disease.
 -0- 6/17/93
 /CONTACT: Mary McConnon of Immunex, 206-587-0430/
 (IMNXD)


CO: Immunex Corp. ST: Washington IN: MTC SU: PER

SW -- SE003 -- 3060 06/17/93 12:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 17, 1993
Words:191
Previous Article:IDEC PHARMACEUTICALS RECEIVES NOTICE OF U.S. PATENT ALLOWANCE FOR MELIMMUNE(TM)-2 CANCER VACCINE: THERAPEUTIC TO TREAT MELANOMA
Next Article:NATIONAL HOME CENTERS, INC. ANNOUNCES PLANS TO ACQUIRE CASH LUMBER COMPANY
Topics:


Related Articles
IMMUNEX APPOINTS STEVEN GILLIS ACTING CHAIRMAN AND CHIEF EXECUTIVE OFFICER
IMMUNEX ELECTS EDWARD V. FRITZKY CHAIRMAN AND CHIEF EXECUTIVE OFFICER
IMMUNEX FOUNDER RESIGNS, CONTINUES AS CONSULTANT
IMMUNEX NAMES TWO OFFICERS
IMMUNEX APPOINTS NEW VICE PRESIDENT, CONTROLLER
IMMUNEX RECRUITS FDA OFFICIAL FOR KEY STRATEGIC POSITION
IMMUNEX ELECTS DOUGLAS WILLIAMS TO BOARD
IMMUNEX APPOINTS LEONARD STEVENS SENIOR VICE PRESIDENT FOR MARKETING AND BUSINESS DEVELOPMENT
IMMUNEX ANNOUNCES EXECUTIVE LEVEL CHANGES
Leslie Garrison Promoted to Immunex Vice President, Clinical Development.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters